However, there is currently insufficient evidence to recommend routine genotyping of PIK3CA in clinical practice, although many studies have been performed regarding the prognostic and therapeutic implications of PIK3CA mutations in breast cancer [8]. This evidence concerns the gene PIK3CA and breast cancer.